Contenido principal

EUROPEAN REFERENCE LABORATORY EURL-IVD SERMAS CONSORTIUM

  • Eurl IVD Logo

    European Reference Laboratory for Class D in vitro diagnostic medical devices (EURL-IVD) in the categories: (I) Detection and quantification of bacterial infection markers (Treponema pallidum) and (II) detection and quantification of herpesvirus infection markers (Citomegalovirus and Epstein-Barr Virus).

    On December 5, 2023, the European Commission published (Regulation (EU) 2023/2713) the designation of 5 laboratories in Europe as European Reference Laboratories (EURL) for high-risk in vitro diagnostic medical devices (IVDs) (Class D). These EURLs have been selected based on the criteria established in the Implementing Regulation (EU) 2022/944.

    The consortium formed by the Medical Microbiology Departments of three hospitals belonging to the Madrid Health Service (SERMAS) has been one of the designated entities, these being Hospital Universitario La Paz, Hospital Universitario Ramón y Cajal and Hospital General Universitario Gregorio Marañón.

  • The EURLs will carry out tasks of conformity assessment of in vitro diagnostic medical devices as set out in Article 100 of Regulation (EU) 2017/746. In summary, the EURLs will be responsible for:

    • Verifying the performance of Class D devices and compliance with common specifications.
    • Conducting batch testing of Class D device products that already have the CE mark.
    • Providing scientific advice to European institutions regarding these devices.
    • Offering recommendations on reference materials and measurement procedures.

    Specifically, the Consortium of Hospitals of the Madrid Health Service (EURL-IVD-SERMAS) will be responsible for verifying the performance of medical devices for the detection and quantification of bacterial infection markers (Treponema pallidum) and the detection and quantification of herpesvirus infection markers (Citomegalovirus and Epstein-Barr Virus).

  • The Microbiology Laboratories of the EURL-IVD SERMAS Consortium, as part of the EURL-IVD, contribute to the Network of European Reference Laboratories with decades of experience in the use and evaluation of medical diagnostic devices. This is evidenced by the thousands of samples processed daily among the three hospitals and the high quality of diagnostic results. The Medical Microbiology Services of the three Hospitals are equipped with state-of-the-art equipment and highly trained personnel. These Services also have demonstrated experience in serological techniques and molecular biology.

  • The microbiology laboratories that form the EURL-IVD SERMAS Consortium will act in a coordinated manner. These laboratories ensure the use of the same methodology and procedures to obtain comparable results.

  • The EURL-IVD will provide service to notified bodies for the evaluation of batches and performance verification of Class D devices according to common specifications or equivalent solutions.

  • The prices that the EURLs are going to use are according to Commission Implementing Regulation (EU) 2022/945 .

    Rules for Setting the Fees for EU Reference Laboratories (EURL)

    1.Fee Coverage Fees levied by EU Reference Laboratories may cover the following categories of costs:

              1.Staff costs: Includes staff hours, travel, accommodation, and subsistence costs.

              2.Equipment costs: Applicable when the equipment is not provided by the manufacturer of the device to be tested.

              3.Consumables, test specimens, and reference materials.

              4.Shipping costs: For sample transportation.

              5.Translation costs.

              6.General laboratory operation costs.

    2.Outsourced Testing When a task is outsourced to another laboratory under a contract, the fees may include the costs paid to that laboratory for completing the requested task.

    3.Fee Calculation Principles

             1.Fees must be non-discriminatory, fair, reasonable, and proportionate to the services provided.

              2.Fees shall be calculated based on incurred costs.

              3.If calculating the incurred costs for a particular category (staff, equipment, consumables, shipping, translation) is unreasonably burdensome, the EURL may estimate the costs based on average costs for that category.

              4.The fee for general operation costs shall be determined as a percentage of the combined costs of the other categories and may not exceed 7% of those costs.

  • Other designated institutions:

    • RISE Research Institutes of Sweden – Sweden
    • Consulting Químico Sanitario SLU – Spain
    • Instituto de Salud Carlos III – Spain
    • Paul-Ehrlich-Institut – Germany
  • Class D device groups covered by the EURL to date:

    • Hepatitis and retroviruses
    • Bacterial agents
    • Herpesvirus
    • Highly pathogenic respiratory viruses
  • EU

    More information

    Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for them.